McDonald’s Corporation (MCD), Novo Nordisk A/S (ADR) (NVO), Colgate-Palmolive Company (CL): A Look At Jim Simons’ Top Picks for the Second Quarter

Another major hedge fund that recently disclosed its long equity positions for the second quarter of 2014 is Jim Simons’ Renaissance Technologies, one of the best performing firms in the sector. The fund acknowledged holding an equity portfolio with a market value of more than $42.8 billion, after starting 453 new positions and selling out of another 494 over the quarter. Let’s, thus, take a look at its top holdings in order to elucidate if any of them deserve further research.

The first two companies in the fund’s list remained unchanged in rank over the period, although the largest stake placed in McDonald’s Corporation (NYSE:MCD) saw the fund trim its exposure by 2%. Renaissance Technologies now owns 8.29 million shares, down from 8.52 million shares by the end of the first quarter. The fund’s position in McDonald’s Corporation (NYSE:MCD) is worth more than $835 million, and accounts for almost 2% of its equity portfolio’s total value.


This $91.8 billion market cap fast food restaurant operator saw its stock price inch almost 4% between April and June. However, the stock fell 7.8% ever since, and now trades at only 17 times the company’s earnings –versus an industry average of 28x P/E.

Other major hedge funds betting on McDonald’s Corporation (NYSE:MCD) are Harris Associates, which owns 3.89 million shares of the company, up 4% over the quarter, and Jean-Marie Eveillard’s First Eagle Investment Management, which started a position, with 3.61 million shares, over second the quarter of 2014.

Novo Nordisk A/S (ADR) (NYSE:NVO) also kept its spot in Mr. Simons’ list. The $189 billion market cap healthcare company witnessed a 5% boost in the fund’s exposure between April and June. Renaissance Technologies declared ownership 16.95 million shares of Novo Nordisk A/S (ADR) (NYSE:NVO), worth more than $783 million. However, following a 2:1 split in late-June, the fund’s holdings are now worth approximately $1.5 billion.

Another investor of the company is Ken Fisher’s Fisher Asset Management, which revealed a slight increase in its stake in Novo Nordisk A/S (ADR) (NYSE:NVO) for the second quarter of the year. Recently, the fund made known its 13.74 million shares position in the company.

Finally, there’s Colgate-Palmolive Company (NYSE:CL), a $58.6 billion market cap global consumer products company that escalated from the sixth position in Mr. Simons’ first quarter portfolio. Following a 30% boost in its stake, the fund holds 9.6 million shares of Colgate-Palmolive Company (NYSE:CL), worth approximately $655 million.

Once again, Renaissance Technologies is among the largest hedge fund shareholders of record, followed by Jean-Marie Eveillard’s First Eagle Investment Management. This last fund owns 4.71 million shares of Colgate-Palmolive Company (NYSE:CL), worth about $321 million. In addition, both these funds have been – and will continue to- benefiting from a $0.36 per share quarterly dividend, which implies a 2.2% yield.

Disclosure: Javier Hasse holds no position in any stocks or funds mentioned

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!